NanoEnTek (039860.KQ) Action Cours

NanoEnTek Inc. manufactures and sells diagnostics and analytical equipment, including cell counting systems like Countess, EVE, and ADAM, gene delivery systems NEON, fluorescence microscopes JuLI, and consumable chips for cell counting. The company also offers diagnostic equipment such as FREND quantitative immunoassay analyzers and ADAM-rWBC for residual white blood cell counting in blood products. Products are sold domestically in Korea and internationally, targeting healthcare providers and biotechnology research institutions. The firm focuses on point of care testing (POCT) medical equipment and biotechnology research applications. NanoEnTek's revenue streams come from the sale of its branded equipment and consumables, with key products including Countess, EVE, ADAM, NEON, JuLI, and FREND systems. The company distributes these products to both domestic and overseas markets, serving customers in medical diagnostics and biotechnology research sectors. Sales of ADAM-rWBC devices for blood product analysis represent a specific segment of their diagnostic equipment portfolio. The business model relies on direct sales of medical and biotechnology equipment, with no mention of subscription services or additional revenue sources. Products are categorized by their application: cell counting, gene delivery, microscopy, and diagnostic analysis, each with dedicated branded systems. The company's focus on POCT and biotechnology research equipment differentiates its offerings in the medical device market.